Sunday, June 21, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 940 of 1,261

  1. US 8084015

    Stabilized synthetic immunogen delivery system

    United Biomedical, Inc. · Granted Dec 27, 2011 · Expires Dec 22, 2031

    granted

  2. US 8084018

    Methods for imaging dopamine transporter level

    Alseres Pharmaceuticals, Inc. · Granted Dec 27, 2011 · Expires Dec 22, 2031

    granted

  3. US 8084016

    Measurement of biosynthesis and breakdown rates of biological molecules that are inaccessible or not easily accessible to direct sampling, non-invasively, by label incorporation into metabolic derivatives and catabolitic products

    The Regents of the University of California · Granted Dec 27, 2011 · Expires Dec 22, 2031

    granted

  4. US 8084417

    Cross-linked glycopeptide-cephalosporin antibiotics

    Theravance, Inc. · Granted Dec 27, 2011 · Expires Dec 22, 2031

    granted

  5. US 8084058

    Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative

    Takeda Pharmaceutical Company Limited · Granted Dec 27, 2011 · Expires Dec 22, 2031

    granted

  6. US 8084199

    Method of diagnosing poor survival prognosis colon cancer using microRNA-21

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES, NATIONAL INSTITUTES OF HEALTH · Granted Dec 27, 2011 · Expires Dec 22, 2031

    granted

  7. US 8084234

    Isolated nucleic acid molecules encoding a fusion protein capable of binding VEGF

    REGENERON PHARMACEUTICALS, INC. · Granted Dec 27, 2011 · Expires Dec 22, 2031

    granted

  8. US 8084415

    Uteroglobin in the treatment of IGA mediated nephropathy

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Dec 27, 2011 · Expires Dec 22, 2031

    granted

  9. US 8084248

    Reverse genetic system for rift valley fever virus and uses thereof

    The Board of Regents of the University of Texas System · Granted Dec 27, 2011 · Expires Dec 22, 2031

    granted

  10. US 8084095

    Ceramic/structural protein composites and method of preparation thereof

    UNIVERSITY OF CONNECTICUT · Granted Dec 27, 2011 · Expires Dec 22, 2031

    granted

  11. US 8084498

    Ketone compounds and compositions for cholesterol management and related uses

    Esperion Therapeutics, Inc. · Granted Dec 27, 2011 · Expires Dec 22, 2031

    granted

  12. US 8084572

    Segmented polymers and their conjugates

    Nektar Therapeutics · Granted Dec 27, 2011 · Expires Dec 22, 2031

    granted

  13. US 8084451

    Heteropyrrole analogs acting on cannabinoid receptors

    UNIVERSITY OF CONNECTICUT · Granted Dec 27, 2011 · Expires Dec 22, 2031

    granted

  14. US 8084599

    Methods and compositions for the specific inhibition of gene expression by double-stranded RNA

    INTEGRATED DNA TECHNOLOGIES, INC. · Granted Dec 27, 2011 · Expires Dec 22, 2031

    granted

  15. US 8084614

    Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

    Neurocrine Biosciences, Inc. · Granted Dec 27, 2011 · Expires Dec 22, 2031

    granted

  16. US 8084630

    Process for the synthesis of ramelteon and its intermediates

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Dec 27, 2011 · Expires Dec 22, 2031

    granted

  17. US 8084594

    H2N3 influenza A viruses and methods of use

    The United States of America, as represented by the Secretary of Agriculture · Granted Dec 27, 2011 · Expires Dec 22, 2031

    granted

  18. US 8084250

    Defensin-antigen fusion proteins

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Dec 27, 2011 · Expires Dec 22, 2031

    granted

  19. US 8080651

    Juvenile hemochromatosis gene (HFE2A), expression products and uses thereof

    Xenon Pharmaceuticals Inc. · Granted Dec 20, 2011 · Expires Dec 15, 2031

    granted

  20. US 8080584

    Delayed release rasagiline citrate formulation

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Dec 20, 2011 · Expires Dec 15, 2031

    granted

  21. US 8080246

    Colony stimulating factor 1 receptor (CSF1R) extracellular domain fusion molecules

    Five Prime Therapeutics, Inc. · Granted Dec 20, 2011 · Expires Dec 15, 2031

    granted

  22. US 8080672

    Crystal form of atorvastatin hemi-calcium and processes for preparation thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Dec 20, 2011 · Expires Dec 15, 2031

    granted

  23. US 8080565

    Substituted 4-amino-benzylpiperidine compounds

    Theravance, Inc. · Granted Dec 20, 2011 · Expires Dec 15, 2031

    granted

  24. US 8080554

    Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Dec 20, 2011 · Expires Dec 15, 2031

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.